EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction

Tengfei Liu, Xiaomeng Song, Xin Guo, Rui Xiao iD, Ru Sun iD, Qiuran Ji, Lu Yu, Yiquan Li, Qingyi Fu, Qidi Xue, Lingjun Kong iD, Lin Chen and 2 more

Advanced Science · 2026

DOI: 10.1002/advs.76033 ↗

At a glance

Journal article in Advanced Science, 2026. Written by Tengfei Liu and 13 co-authors. Institution: Department of Pharmacology, School of Basic Medical Sciences and Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.…. Major MEDLINE topics: Protein-Arginine N-Methyltransferases, Mitochondria, Dopaminergic Neurons, Parkinson Disease. 68 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Protein arginine methyltransferases (PRMTs) catalyze protein arginine methylation and play a crucial role in the pathogenesis of diseases. Mitochondrial dysfunction is implicated in the neurodegeneration of Parkinson's disease (PD). However, whether protein arginine methyltransferase 9 (PRMT9), which is found in mitochondria, is involved in PD remains unclear. In this study, we found that PRMT9 was markedly increased in the nigrostriatal region of PD mice induced by MPTP and in SH‐SY5Y cells stimulated with MPP + . In MPP + ‐exposed SH‐SY5Y cells, PRMT9 translocated to mitochondria and exacerbated mitochondrial injury, manifested as decreased mitochondrial membrane potential, reduced ATP production, elevated ROS levels, and mitochondrial fragmentation. Furthermore, PRMT9 deficiency significantly alleviated dopaminergic (DA) neurodegeneration induced by MPTP, while PRMT9 overexpression aggravated MPTP‐induced neurodegeneration. Mechanistically, PRMT9 directly interacted with dual‐specificity phosphatase 26 (DUSP26) and catalyzed its arginine methylation at residue R29, which then promoted the polyubiquitination and proteasomal degradation of DUSP26 mediated by Trim32. Therefore, PRMT9 drove DA neurodegeneration in PD by promoting DUSP26 degradation and inducing mitochondrial dysfunction. Our study identified PRMT9 as a novel potential therapeutic target and a pharmaceutical intervention targeting the interaction between PRMT9 and DUSP26 may provide a promising strategy for PD.

Subjects

MeSH terms (MEDLINE)

Protein-Arginine N-MethyltransferasesMitochondriaDopaminergic NeuronsParkinson DiseaseDual-Specificity PhosphatasesAnimalsMiceHumansDisease Models, AnimalMice, Inbred C57BLMale

Author keywords

DUSP26PRMT9Parkinson's diseasearginine methylationmitochondrianeurodegeneration

Substances

Protein-Arginine N-MethyltransferasesDual-Specificity Phosphatases

Authors and institutions

  • Department of Pharmacology, School of Basic Medical Sciences and Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P. R. China.
  • Research Center for Basic Medical Sciences, Qilu Hospital, Shandong University, Jinan, Shandong, P. R. China.
  • Department of Neurosurgery, The First Medical Centre, Chinese PLA General Hospital, Beijing, P. R. China.
  • Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P. R. China.
  • Key Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, P. R. China.
  • Shenzhen Research Institute of Shandong University, Shenzhen, Guangdong, P. R. China.

ORCID profiles: Rui Xiao, Ru Sun, Lingjun Kong

Funding

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation

Cite

APA

Liu, T., Song, X., Guo, X., Xiao, R., Sun, R., Ji, Q., Yu, L., Li, Y., Fu, Q., Xue, Q., Kong, L., Chen, L., Gao, C., & Liu, H. (2026). PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction. Advanced Science. https://doi.org/10.1002/advs.76033

Vancouver

Liu T, Song X, Guo X, Xiao R, Sun R, Ji Q, et al. PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction. Advanced Science. 2026. doi:10.1002/advs.76033

BibTeX
@article{Liu2026,
  author = {Liu, Tengfei and Song, Xiaomeng and Guo, Xin and Xiao, Rui and Sun, Ru and Ji, Qiuran and Yu, Lu and Li, Yiquan and Fu, Qingyi and Xue, Qidi and Kong, Lingjun and Chen, Lin and Gao, Chengjiang and Liu, Huiqing},
  title = {PRMT9 Aggravated Dopaminergic Neurodegeneration in Parkinson's Disease Model by Facilitating the Degradation of DUSP26 and Inducing Mitochondrial Dysfunction},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76033}
}
Start for free →